PHUNWARE INC (PHUN)

US71948P2092 - Common Stock

4.76  +0.3 (+6.85%)

After market: 4.62 -0.14 (-2.94%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PHUN. PHUN was compared to 279 industry peers in the Software industry. PHUN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PHUN has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year PHUN has reported negative net income.
PHUN had a negative operating cash flow in the past year.
In the past 5 years PHUN always reported negative net income.
PHUN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

PHUN has a worse Return On Assets (-203.38%) than 97.13% of its industry peers.
With a Return On Equity value of -332.97%, PHUN is not doing good in the industry: 85.30% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -203.38%
ROE -332.97%
ROIC N/A
ROA(3y)-310.42%
ROA(5y)-209.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PHUN has a better Gross Margin (111.28%) than 99.64% of its industry peers.
In the last couple of years the Gross Margin of PHUN has declined.
The Profit Margin and Operating Margin are not available for PHUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 111.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.32%
GM growth 5Y-10.8%

6

2. Health

2.1 Basic Checks

PHUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PHUN has more shares outstanding
The number of shares outstanding for PHUN has been increased compared to 5 years ago.
The debt/assets ratio for PHUN is higher compared to a year ago.

2.2 Solvency

PHUN has an Altman-Z score of -16.10. This is a bad value and indicates that PHUN is not financially healthy and even has some risk of bankruptcy.
PHUN has a Altman-Z score of -16.10. This is amonst the worse of the industry: PHUN underperforms 93.19% of its industry peers.
PHUN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -16.1
ROIC/WACCN/A
WACC12.66%

2.3 Liquidity

A Current Ratio of 2.82 indicates that PHUN has no problem at all paying its short term obligations.
PHUN has a Current ratio of 2.82. This is in the better half of the industry: PHUN outperforms 73.84% of its industry peers.
A Quick Ratio of 2.82 indicates that PHUN has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.82, PHUN is doing good in the industry, outperforming 74.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.82
Quick Ratio 2.82

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.46% over the past year.
PHUN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.90%.
The Revenue for PHUN have been decreasing by -30.99% on average. This is quite bad
EPS 1Y (TTM)68.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.88%
Revenue 1Y (TTM)-25.9%
Revenue growth 3Y-21.53%
Revenue growth 5Y-30.99%
Sales Q2Q%-76.18%

3.2 Future

The Earnings Per Share is expected to grow by 39.73% on average over the next years. This is a very strong growth
Based on estimates for the next years, PHUN will show a very negative growth in Revenue. The Revenue will decrease by -17.65% on average per year.
EPS Next Y93.46%
EPS Next 2Y39.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-60.3%
Revenue Next 2Y-17.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

PHUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PHUN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PHUN's earnings are expected to grow with 39.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.73%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PHUN!.
Industry RankSector Rank
Dividend Yield N/A

PHUNWARE INC

NASDAQ:PHUN (11/18/2024, 8:00:00 PM)

After market: 4.62 -0.14 (-2.94%)

4.76

+0.3 (+6.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap55.88M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -203.38%
ROE -332.97%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 111.28%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.82
Quick Ratio 2.82
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)68.46%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y93.46%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-25.9%
Revenue growth 3Y-21.53%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y